2025-08-29 00:54:03
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Ortin Laboratories Q3 FY22 net loss at Rs. 9.03 lakhs
Posted On : 2022-02-16 17:47:52( TIMEZONE : IST )
Ortin Laboratories Limited has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 1.6586 crores during the period ended December 31, 2021 as compared to Rs. 2.3302 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. -0.0903 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 0.0538 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. -0.11 for the period ended December 31, 2021 as compared to Rs. 0.07 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 1.6586 crs | ₹2.3302 crs |  -28.82% |
| Net Profit | ₹-0.0903 crs | ₹0.0538 crs | -267.84% |
| EPS | ₹-0.11 | ₹0.07 | -257.14% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 1.6586 crores during the period ended December 31, 2021 as compared to Rs.51.8888 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.-0.0903 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.0.5955 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.-0.11 for the period ended December 31, 2021 as compared to Rs.0.35 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 1.6586 crs | ₹51.8888 crs | -96.80% |
| Net Profit | ₹-0.0903 crs | ₹0.5955 crs | -115.16% |
| EPS | ₹-0.11 | ₹0.35 | -131.43% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.5.9736 crores during the 9 Months period ended December 31, 2021 as compared to Rs.207.3318 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.0.0546 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.2.8924 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.0.07 for the 9 Months period ended December 31, 2021 as compared to Rs.1.71 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹5.9736 crs | ₹207.3318 crs | -97.12% |
| Net Profit | ₹0.0546 crs | ₹2.8924 crs | -98.11% |
| EPS | ₹0.07 | ₹1.71 | -95.91% |
Shares of Ortin Laboratories Limited was last trading in BSE at Rs. 28.65 as compared to the previous close of Rs. 28.75. The total number of shares traded during the day was 5932 in over 148 trades.
The stock hit an intraday high of Rs. 29.80 and intraday low of 28.00. The net turnover during the day was Rs. 173176.00.
